Pharmacological profile of T-0632, a novel potent and selective CCK(A) receptor antagonist, in vivo

European Journal of Pharmacology

Volumn 312, Issue 2, 1996, Pages 227-233

  Taniguchi, Hiroyuki ^a   Yazaki, Naoko ^a   Yomota, Eiji ^a   Shikano, Toshirou ^a   Endo, Toshio ^a   Nagasaki, Masaaki ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

CCK(A) receptor; Gallbladder contraction; Gastric emptying; Pancreatic secretion; T 0632

Indexed keywords

CERULETIDE; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; DEVAZEPIDE; LOXIGLUMIDE;

AMYLASE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; GALLBLADDER EMPTYING; INTRAGASTRIC DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PANCREAS SECRETION; PANCREATITIS; PRIORITY JOURNAL; RAT; STOMACH EMPTYING; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030603211     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00473-6     Document Type: Article

References (21)

1. Beglinger, C., S. Dill, B. Meyer, B. Werth and G. Adler, 1989, Treatment of biliary colic with loxiglumide, Lancet 8655, 167.
2. Berlin, R.G. and R.M. Freidinger, 1991, Characterization of MK-329, In: Cholecystokinin Antagonists in Gastroenterology, ed. G. Adler and C. Beglinger (Springer-Verlag, Berlin, Heidelberg) p.70.
3. Cann, P.A., L.C. Rovati, H. Smart, R.C. Spiller and P.J. Whorwell, 1993, Loxiglumide, a CCK-A antagonist, in irritable bowel syndrome: a pilot multicenter clinical study, Gastroenterology 104, A486.
4. Cerezo, J.G., R. Codoceo, P.F. Calle, F. Molina, J.M. Tenias and J.J. Vazquez, 1991, Basal and postprandial cholecystokinin values in chronic pancreatitis with and without abdominal pain, Digestion 48, 134.
5. Chang, R.S.L. and V.J. Lotti, 1986, Biochemical and pharmacological characterization of an extremeiy potent and selective nonpeptide cholecystokinin antagonist, Proc. Natl. Acad. Sxi. USA 83, 4923.
6. Chang, R.S.L., V.J. Lotti, R.L. Monaghan, J. Birnbaum, E.O. Stapley, M.A. Goetz, G. Albers-Schbönberg, A.A. Patchett, J.M. Liesch, O.D. Hensens and J.P. Springer, 1985, A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from aspergillus alliaceus, Science 230, 177.
7. Crawley, J.N. and R.L. Corwin, 1994, Biological actions of cholecystokinin, Peptides 15, 731.
8. D'Amato, M. and L.C. Rovati, 1995, CCK-A antagonists: which and how, Eur. J. Clin. Invest. 25, 213.
9. A receptor antagonists in gastroenterology, Drug News Perspect. 7, 87.
10. 1 receptor agonist, on pancreatic exocrine secretion in anesthetized dogs, Eur. J. Pharmacol. 218, 237.
11. Liddle, R.A., 1994, Cholecystokinin, in: Gut Peptide, eds. Walsh, J.H. and G.J. Dockray (Raven Press, New York) p. 175.
12. Lignon, M.F., M.C. Galas, M. Rodriguez, J. Laur, A. Aumelas and J. Martinez, 1987, A synthetic peptide derivatives that is a cholecystokinin receptor antagonist, J. Biol. Chem. 262, 7226.
13. Lotti, V.J., R.G. Pendlenton, R.J. Gould, H.M. Hanson, R.S.L. Chang and B.V. Clineschmidt, 1987, In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist, J. Pharmacol. Exp. Ther. 241, 103.
14. Makovec, F., M. Bani, R. Cereda, R. Chistè, M.A. Pacini, L. Revel and L.C. Rovati, 1987, Antispasmodic activity on the gallbladder of the mouse of CR 1409 (lorglumide) a potent antagonist of peripheral CCK, Pharmacol. Res. Commun. 19, 41.
15. Niederau, C., L.D. Ferrell and J.H. Grendell, 1985, Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, Benzotript, and secretin, Gastroenterology 88, 1192.
16. Perdikis, G., P. Wilson, R.A. Hinder, E.J. Redmond, G.J. Wetscher, S. Saeki and T.E. Adrian, 1994, Gastroesophageal reflux disease is associated with enteric hormone abnormalities, Am. J. Surg. 167, 186.
17. Rovati, L.C., 1991, Perspectives of CCK antagonists in pancreatic research and clinical use, Int. J. Pancreatol. 8, 215.
18. Setnikar, I., M. Bani, R. Cereda, R. Chisté, F. Makovec, M.A. Pacini and L. Revel, 1987a, Anticholecystokinin activities of loxiglumide, Arzneim.-Forsch./Drug Res. 37, 1168.
19. Setnikar, I., M. Bani, R. Cereda, R. Chisté, F. Makovec, M.A. Pacini, L. Revel, L.C. Rovati and L.A. Rovati, 1987b, Pharmacological characterization of a new potent and specific nonpolypeptidic cholecystokinin antagonist, Arzneim.-Forsch./Drug Res. 37, 703.
20. Spanarkel, M., J. Martinez, C. Briet, R.T. Jensen and J.D. Gardner, 1983, Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists, J. Biol. Chem. 258, 6746.
21. A receptor antagonist, in vitro, Eur. J. Pharmacol. 304, 147.